Emerging Infectious Disease Diagnostics Market Share Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Emerging Infectious Disease Diagnostics Market?
The market size of the emerging infectious disease diagnostics has seen a robust expansion in the past years. The market which stands at $22.13 billion in 2024, is poised to reach $24.34 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.0%. The rise during the past period is associated with the growing need for point-of-care diagnostics, the escalating occurrence of infectious diseases, the increasing population density worldwide, a spike in incidents of infectious diseases, and augmented healthcare expenditure.

The market size for diagnostics of emerging infectious diseases is set to experience robust expansion in the forthcoming years, reaching $35.21 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. The predicted rise during this forecast period can be linked to an increasing occurrence of zoonotic diseases, notable enhancements in regulatory changes and assistance, creation of universal vaccines, an amplified emphasis on a singular health approach, and escalated government endorsement and funding. Key trends for the forecast period encompass advancements in technology, next-generation sequencing (NGS), isothermal amplification methods, telemedicine and remote diagnostics, along with monitoring of environmental pathogens.

What Factors Are Propelling the Expansion of the Emerging Infectious Disease Diagnostics Market?
The growth of the emerging infectious disease diagnostics market is expected to be driven by the increasing occurrence of zoonotic diseases. Those are infections that humans can get from animals. They can be caused by bacteria, viruses, parasites or fungi. More frequent human-wildlife interactions, destruction of habitats and global travel are the main reasons behind the rising incidence of these diseases as they facilitate the spread of pathogens across species. The role of emerging infectious disease diagnostics is crucial in controlling these diseases, as it allows for the early detection and correct identification of pathogens, which in turn leads to timely intervention, effective remedy and improved handling of disease outbreaks, thus minimising the transmission from animals to humans. For example, the 2022 Zoonotic Disease Report issued by the US-based government administration, State of West Virginia, in the MMWR Year 2022 reported that the number of Lyme disease cases had increased to 2,449 in February 2024, which was an increase from 1,788 cases in 2021. Therefore, the upsurge in zoonotic diseases is considered to be facilitating the growth of the emerging infectious disease diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20548&type=smp

Which Businesses Are at the Forefront of Emerging Infectious Disease Diagnostics Market Development?
Major companies operating in the emerging infectious disease diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.

Which Businesses Are at the Forefront of Market Development?
Pivotal companies in the nascent infectious disease diagnostics market are concentrating on technological advancements such as molecular diagnostic systems to establish a competitive advantage. These molecular diagnostic tools utilize nucleic acid amplification methods to detect pathogens with utmost sensitivity and precision, allowing for accurate diagnosis and prompt detection. In a case in point from May 2022, Becton Dickinson and Company, a biomedical equipment producer based in the US, introduced the BD COR MX/PX System - a fully automated, high-capacity diagnostic platform. This system enhances lab efficiency by automating the entire molecular process, from handling samples to generating results. Its first assay, the BD CTGCTV2, identifies three common non-viral sexually transmitted diseases (STDs). Capable of processing up to 1,700 specimens via onboard reagent and sample capacity, the BD COR MX/PX System enables more than seven hours of uninterrupted operation and delivers up to 1,000 results within 24 hours, substantially minimizing manual intervention by lab technicians.

How Is the Emerging Infectious Disease Diagnostics Market Segmented?
The emerging infectious disease diagnostics market covered in this report is segmented -

1) By Infection Type: Viral, Bacterial, Fungal, Other Infections
2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types
3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies
4) By Application: Laboratory Testing, Point-of-Care Testing
5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users

Subsegments:
1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections
2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria
3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections
4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/emerging-infectious-disease-diagnostics-global-market-report

Where Is the Emerging Infectious Disease Diagnostics Market Growth Most Prominent?
North America was the largest region in the emerging infectious disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Emerging Infectious Disease Diagnostics Global Market Report?

- Market Size Analysis: Analyze the emerging infectious disease diagnostics Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the emerging infectious disease diagnostics market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall emerging infectious disease diagnostics market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the emerging infectious disease diagnostics market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20548

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.